@ZacharyBrennan We know you are not serious. But thanks for the laugh 😂
English
msp12389
1.6K posts
Makary’s biggest legacy? Installing political operatives to serve as center directors — blurring the line in the sand between science and politics at an agency that once was the gold standard for relying on data
Rapid Response 47@RapidResponse47
English
Maybe someone sends him screenshots
It’s over $6 in my area
*Walter Bloomberg@DeItaone
TRUMP: GAS PRICES ARE NOT VERY HIGH
English
@MBbiotech @ewarren Agree w you but in all fairness she said 0.15% not 15%
English
A wealth tax on the top .15% of the richest families would generate $6.2 trillion in revenue.
That could pay for:
Universal childcare
Millions of new homes
Slashing child poverty
Medicare for people aged 55+
Universal paid family leave
Tuition-free community college
And more.
English
@saxena_puru Read the CENTCOM notice. Big difference. You know better.
English
@twotreesthere It is also worth noting that the FDA granted $REPL breakthrough designation AFTER they had reviewed the primary analysis data to be included in the BLA, and didn't raise any of those supposed concerns on the study then
English
$REPL When >8500 US patients die each year [1], regulatory "flexibility" is NOT accepting & rejecting a BLA twice for the same reasons [2]
"Flexibility" is to risk the uncertainty of if, or how many patients may be saved, given the access [3].
English
$REPL This thread 👍 - but hey, "innovation died today" 🤷♂️🤯
Sally Church@MaverickNY
Just how bad is it? It's pretty bad in my book. The FDA letter documents a pattern going well beyond weak science into what seems like a deliberate strategy to ignore regulators and hope for the best.
English
$REPL What a pitiful and ridiculous press release ir.replimune.com/news-releases/…
English
@Sanctuary_Bio One would have to be a complete moron to buy today's expiration 🤣 can't feel bad
English
$REPL so uh...wtf is going on. There are options expiring today
the CRL was published by the FDA over 3 hours ago. What kind of pure shitco behavior is this lol
WC@Sanctuary_Bio
@RayneWothbaum for some reason the company itself still hasn't PR'ed yet ir.replimune.com/press-releases dont think they will move to T2 and subsequent T3 until they do
English
Dude, they told them >5 years ago, long before you and everyone elese started ranting about the "new" "bad" FDA"
"Or is it the FDA that's lost all credibility. After a year of politically aligning staff, it will take a long time repairing the agency." $REPL
Dirk Haussecker@RNAiAnalyst
$repl all the docs that wrote the letter last year for why RP1 should be approved and attensed the subsequent FDA meeting obviously have no credibility. Or is it the FDA that's lost all credibility. After a year of politically aligning staff, it will take a long time repairing the agency.
English
aite. DMs are still open for guesses but will be shutting down public responses. Only one person got it right.
Can't wait to disclose later this month. Guarantee this will be your response
GIF
WC@Sanctuary_Bio
Someone got it correct in my DMs. So this is a guarantee the name is real lol. Think outside the box!
English
$REPL A lot of biotwitter "influencers" looking very foolish today- wild CRL download.open.fda.gov/crl/CRL_BLA125…
English
$REPL but but but... Prasad... FDA...
GIF
Adu Subramanian@plainyogurt21
Can they read? seriously dude, this is egregious behavior from $REPL
English
Alguien me puede confirmar si los post se están traduciendo automáticamente?
Parece que Grok y X están desplegando la traducción automática al idioma del lector.
x.com/TaxiBiotech/st…
TaxiBiotech@TaxiBiotech
Resumen Biotech del Día 🧬(detalles en el video) $ORGO +5% Organogenesis datos positivos + BLA $SNY Sanofi. Nanobodies: éxito en Fase 2 $KPRX Kiora (+20%) tras financiación $24M $NGEN NervGen Fase 3 para tetraplejia. $LUNAI Colaboración IA + guerra bacteriológica/química. ¿estamos ya en ese punto? $CLMB + $NXTC Fast Track $ARTL Sigue en Nasdaq $ASND Inicia comercialización en USA. 🇺🇸 $GLSI $ACIU $LLY $CRBP youtube.com/shorts/UTPO3i8… #Biotech #Stocks #Trading #Investing #FDA
Español
$ALMS Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis | Alumis Inc. investors.alumis.com/news-releases/…
English
TBF though, biotwitter hasn't been this funny for about two years.
English
$MAZE - Analysts pitching tent poles over the AMKD data, yet stock is down pre market. What's the disconnect?
English